Results from Figure 2 and Table 3 demonstrate a significant difference in IL-10 plasma levels between -1082 A/G (rs1800896) NPC patients and control subjects genotype carriers (P = 0.023). The gene discussed is IL10; the disease is nasopharyngeal carcinoma.